Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Idiopathic thrombocytopenic purpura and MMR vaccine.

Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B.

Arch Dis Child. 2001 Mar;84(3):227-9.

2.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD004407. doi: 10.1002/14651858.CD004407.pub3. Review.

PMID:
22336803
3.

Vaccine administration and the development of immune thrombocytopenic purpura in children.

Cecinati V, Principi N, Brescia L, Giordano P, Esposito S.

Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16. Review.

4.

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.

Mantadakis E, Farmaki E, Buchanan GR.

J Pediatr. 2010 Apr;156(4):623-8. doi: 10.1016/j.jpeds.2009.10.015. Epub 2010 Jan 25. Review.

PMID:
20097358
5.

Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.

Owatanapanich S, Wanlapakorn N, Tangsiri R, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2014 Sep;45(5):1053-7. Review.

PMID:
25417506
6.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Jefferson T, Rivetti A, Price D.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004407. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD004407.

PMID:
16235361
8.
9.

The epidemiology of immune thrombocytopenic purpura.

Fogarty PF, Segal JB.

Curr Opin Hematol. 2007 Sep;14(5):515-9. Review.

PMID:
17934361

Supplemental Content

Support Center